CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Sodium Sulfacetamide 8% and Sulfur 4%

Sodium Sulfacetamide 8% Sulfur 4%· ingredient sulfacetamidePreparations containing sulfur· SULFACETAMIDE SODIUM 80 mg/g; SULFUR 40 mg/g; SULFACETAMIDE SODIUM 80 mg/mL; SULFUR 40 mg/mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.06467
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per ML — the trend nobody else shows. 6 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other sulfacetamide products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.

ProductNADAC / MLvs this
Sodium Sulfacetamide 9% and Sulfur 4.5% Cleanser$0.07818+$0.01350
OVACE$0.11417+$0.04950
Plexion$0.12999+$0.06530
AVAR$0.17118+$0.10650
Sodium Sulfacetamide 9% and Sulfur 4% Cleanser$0.36031+$0.29560
Klaron$0.53594+$0.47130
Avar-e$0.68695+$0.62230
sulfacetamide sodium$1.86+$1.80

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.